Skip to content

Author

Melissa Naylor

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

BACKGROUND Narcolepsy type 1 is characterized by excessive daytime sleepiness, cataplexy, disrupted sleep, sleep paralysis, and hypnagogic or hypnopompic hallucinations. Oveporexton (TAK-861), an oral orexin receptor 2-selective agonist, reduced symptoms of narcolepsy type 1 in a previous phase 2 trial. METHODS We co...

Y. Dauvilliers, Emmanuel Mignot, Jakub Antczak et al. · 1 citation
Open access Aug 2026

An actigraphy-based algorithm to assess daytime napping in people with narcolepsy type 1.

STUDY OBJECTIVES Excessive daytime sleepiness is a defining symptom of narcolepsy, affecting daily functioning and quality of life. We developed and evaluated an actigraphy-based nap detection algorithm to objectively estimate daytime naps, a key manifestation of excessive daytime sleepiness. METHODS The nap detectio...

R. Torres, Rahul Ghosal, Melissa Naylor et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.